LMAT - CIK 0001158895
LEMAITRE VASCULAR INC trades as LMAT and has a market capitalization of $2.13 B, making it the #2056 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $249.60M, up 13.5% from the prior year and net income of $57.70M. This page tracks LEMAITRE VASCULAR INC through 1,849 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years LEMAITRE VASCULAR INC's revenue grew from $89.15M to $249.60M, a compound annual growth rate of 12.1%. Net profit margin expanded from 11.9% to 23.1% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-14 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-07 |
| Insider sale notice | 144 | 2026-05-07 |
Artegraft grew 36% worldwide in Q1, bolstered by its international launch. Grafts (+20%), valvulotomes (+15%), and carotid shunts (+11%) each posted record sales. The three geographies also posted records: EMEA (+20%), APAC (+18%), and the Americas (+7%).
Access to the live call is available by registering online here . All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at www.lemaitre.com/investor .
Q3 2025 results include a non-recurring benefit from the Employee Retention Tax Credit. Non-GAAP adjusted figures exclude this benefit. A reconciliation of GAAP to non-GAAP results is included.
The largest companies sharing LEMAITRE VASCULAR INC's SEC industry classification (surgical & medical instruments & apparatus).
LEMAITRE VASCULAR INC (LMAT) has a market capitalization of $2.13 B as of 2026-06-10, ranking #2056 among US-listed companies.
LEMAITRE VASCULAR INC reported revenue of $249.60M for fiscal year 2025, an increase of 13.5% year over year.
Yes. LEMAITRE VASCULAR INC reported net income of $57.70M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.